Brief: Noxopharm Says HY Loss After Income Tax Expense Attributable A$8.6 Mln
21/02/2022 07:08
Feb 21 (Reuters) - Noxopharm Ltd NOX.AX :
* HY LOSS AFTER INCOME TAX EXPENSE ATTRIBUTABLE A$8.6
MILLION
VERSUS LOSS A$6.7 MILLION
Source text for Eikon: ID:nASX7KGktb
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer